Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo Journal Article


Authors: Takai, Y.; Canning, J.; Perez, G. I.; Pru, J. K.; Schlezinger, J. J.; Sherr, D. H.; Kolesnick, R. N.; Yuan, J.; Flavell, R. A.; Korsmeyer, S. J.; Tilly, J. L.
Article Title: Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo
Abstract: The industrial chemical, 4-vinylcyclohexene diepoxide (VCD), kills oocytes within immature follicles in the ovaries of mice and rats and is considered a potential occupational health hazard. It has been reported that VCD-induced follicle loss occurs via a cell death process involving elevated expression of Bax, a proapoptotic Bcl-2 family member, and increased caspase-3-like activity. We have previously shown that oocytes lacking acid sphingomyelinase (ASMase; an enzyme that generates the proapoptotic stress sensor ceramide), the aromatic hydrocarbon receptor (Ahr), Bax, or caspase-2 are resistant to apoptosis induced by other chemical toxicants. Therefore, this study was designed to investigate the functional importance of ASMase, Ahr, Bax, and caspase-2 as well as the related executioner enzyme caspase-3 to VCD-induced ovotoxicity in mice using gene knockout technology. For each gene mutant mouse line, wild-type and homozygous-null female siblings derived from heterozygous matings were given once-daily ip injections of either vehicle (sesame oil) or VCD (80 mg/kg body weight) for 15 d (three or four mice per treatment group per genotype). Ovaries were collected 24 h after the final injection and analyzed for the total number of non-atretic primordial and primary follicles remaining per ovary. No differences in the extent of primordial or primary follicle destruction resulting from VCD exposure were observed in wild-type vs. ASMase- or Ahr-deficient mice. By contrast, the extent of VCD-induced primordial follicle depletion in Bax-deficient mice (45 ± 11%) was significantly (P < 0.05) lower than that in wild-type females (85 ± 2%). The extent of primary follicle loss in bax-null mice exposed to VCD (3 ± 22%) was also significantly (P < 0.05) lower than that in their wild-type sisters (86 ± 4%). In caspase-2-deficient mice, significantly (P < 0.05) fewer oocyte-containing primary follicles were destroyed by VCD (17 ± 19%) vs. wild-type controls (71 ± 6%); however, no significant difference in the extent of VCD-induced primordial follicle destruction was observed in caspase-2-null vs. wild-type females. Finally, in caspase-3-deficient mice, significantly (P < 0.05) fewer oocyte-containing primary follicles were destroyed by VCD (33 ± 3%) vs. wild-type controls (71 ± 2%); however, no significant difference in the extent of VCD-induced primordial follicle destruction was observed in caspase-3-null vs. wild-type females. We conclude that Bax, caspase-2, and caspase-3, but not ASMase or Ahr, are functionally important in VCD-induced follicle loss. However, as a loss of Bax, caspase-2, or caspase-3 function conveyed only partial protection from the ovotoxic effects of VCD, other cell death pathways that either function independently of Bax, caspase-2, and caspase-3 or are not apoptotic in nature are also involved.
Keywords: controlled study; protein expression; unclassified drug; gene mutation; proto-oncogene proteins; nonhuman; protein function; animal cell; mouse; oocyte; animals; mice; mice, knockout; oocytes; cell death; apoptosis; cell line; protein; genotype; in vivo study; caspase 3; cytotoxicity; caspases; wild type; mice, inbred c57bl; ovary follicle; homozygosity; statistical significance; species specificity; heterozygosity; outcomes research; cell count; cell protection; proto-oncogene proteins c-bcl-2; ovarian follicle; knockout gene; receptors, aryl hydrocarbon; sphingomyelin phosphodiesterase; cyclohexanes; protein bax; cyclohexenes; bcl-2-associated x protein; epoxide; cell loss; caspase 2; male; female; priority journal; article; protein ahr; sesame seed oil
Journal Title: Endocrinology
Volume: 144
Issue: 1
ISSN: 0013-7227
Publisher: Endocrine Society  
Date Published: 2003-01-01
Start Page: 69
End Page: 74
Language: English
DOI: 10.1210/en.2002-220814
PUBMED: 12488331
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard N Kolesnick
    299 Kolesnick